Suchergebnisse - "Cai, Yu-Wen"

PubPharm (8)

1

Targeting EMSY-mediated methionine metabolism is a potential therapeutic strategy for triple-negative breast cancer

enthalten in: Cell reports. Medicine | 2024

von Liu, C. | Chen, L. | Cai, Y. | +5

2

Combined Single-Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2023

von Liu, Y. | Ge, J. | Chen, Y. | +9

3

De-escalation of five-year adjuvant endocrine therapy in patients with estrogen receptor-low positive (immunohistochemistry staining 1%-10%) breast cancer : Propensity-matched analysis from a prospectively maintained cohort

enthalten in: Cancer | 2022

von Cai, Y. | Shao, Z. | Yu, K.

CommentIn: Cancer. 2022 May 1;128(9):1724-1726. - PMID 35213039

4

Determining the Optimal (Neo)Adjuvant Regimen for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Regarding Survival Outcome : A Network Meta-Analysis

enthalten in: Frontiers in immunology | 2022

von Cai, Y. | Shao, Z. | Yu, K.

5

De‐escalation of five‐year adjuvant endocrine therapy in patients with estrogen receptor‐low positive (immunohistochemistry staining 1%‐10%) breast cancer : Propensity‐matched analysis from a prospectively maintained cohort

enthalten in: Cancer | 2022

von Cai, Y. | Shao, Z. | Yu, K.

6

Deep learning driven colorectal lesion detection in gastrointestinal endoscopic and pathological imaging

enthalten in: World journal of clinical cases | 2021

von Cai, Y. | Dong, F. | Shi, Y. | +7

7

Estrogen receptor-low breast cancer : Biology chaos and treatment paradox

enthalten in: Cancer communications (London, England) | 2021

von Yu, K. | Cai, Y. | Wu, S. | +2

8

Estrogen receptor‐low breast cancer : Biology chaos and treatment paradox

enthalten in: Cancer Communications | 2021

von Yu, K. | Cai, Y. | Wu, S. | +2

1
[1]